Skip to main content
FULC logo

FULC · Fulcrum Therapeutics, Inc. · Analyst Estimates

Track FULC — free
$3.70 +0.00 (+0.00%)
Market Cap
$285.35M
Shares
76.30M
Volume · Oct 1 82.27K Avg daily vol (3M) 1.6M

Analyst Estimates

Compare analyst forecasts for Fulcrum Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-20 14:47 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.80759
-0.65586
-0.51
—
-0.6569
-0.76097
-0.6569
-0.82187
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
1
1
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.46
-0.54758
-0.01
—
-0.48793
-0.58057
-0.48793
-0.65822
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.1334
-0.1067
-0.08
—
-0.11113
-0.15323
-0.11113
-0.17807
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.08329
-0.06664
-0.05
—
-0.06443
-0.13865
-0.06443
-0.16673
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1680581 CUSIP 359616109 13F (30d) 4 filings 4 filers Visit website Investor relations